
Positive trial results for two DED therapies
Oyster Point Pharma says two separate Phase 2b clinical trials evaluating the company’s novel therapies for the treatment of Dry Eye Disease (DED) have demonstrated improvement in Schirmer’s score and

Oyster Point Pharma says two separate Phase 2b clinical trials evaluating the company’s novel therapies for the treatment of Dry Eye Disease (DED) have demonstrated improvement in Schirmer’s score and

Retinal imaging device manufacturer Optos and Amydis, which has developed a pipeline of compounds to detect amyloid proteins in the retina, are collaborating to develop an early diagnostic test for

A new kind of lens, specially engineered for people with strong protan-type colour vision deficiency has been released and the manufacturers claim it helps people with strong protanomaly perceive a

A team of ophthalmologists says the amount of harm being done by unapproved stem cell therapy is underreported.The team went looking for scientific evidence in support of commercially available “cell

Auckland Eye’s Dr Dean Corbett is only the second Kiwi ophthalmologist in history to be invited to join the prestigious International Intra-Ocular Implant Club (IIIC).

Britain’s National Theatre is offering audience members with hearing loss a service which displays captions on smart glasses during performances.The glasses display a synchronised transcript of the

Progress is being made with a bionic eye being developed in Australia, with medical researchers saying they have successfully restored a sense of vision in four people who have gone blind from

Cataract patients turned down for public hospital surgery and unable to fund their own can now have their cataracts treated for free thanks to the generosity of surgeons working under the umbrella of the Auckland Regional Charity Hospital (ARCH).

Two Flinders University eye research projects focusing on glaucoma and one looking for ways to reduce the suicide rate among doctors are among 35 new health and medical research projects to receive

Results of an Australian clinical trial show a four-fold reduction in the rate of progression to late stage AMD in 76% of intermediate age-related macular degeneration (iAMD) patients who received

Researchers are testing a new computer game which they hope could hold the key to helping visually-impaired children lead independent lives. Developed by a team of neuroscientists and video game

By comparing genetic sequences in the eye tumours of children whose cancers spread with tumours that didn’t spread, Johns Hopkins Medicine researchers say they have found new evidence that a domino